| Level/ Typ |
Code |
Anzeigename |
Codesystem |
| 0‑S |
1
|
Allgemeiner Laborbefund
|
1.2.40.0.34.5.11 |
| 1‑L |
10
|
Probeninformation
|
1.2.40.0.34.5.11 |
| 1‑L |
20
|
Befundbewertung
|
1.2.40.0.34.5.11 |
| 1‑S |
100
|
Blutgruppenserologie/Immungenetik
|
1.2.40.0.34.5.11 |
| 2‑L |
101
|
Blutgruppenserologie
|
1.2.40.0.34.5.11 |
| 2‑L |
102
|
HLA-Diagnostik
|
1.2.40.0.34.5.11 |
| 2‑L |
103
|
HPA-Diagnostik
|
1.2.40.0.34.5.11 |
| 1‑S |
200
|
Blutgasanalyse
|
1.2.40.0.34.5.11 |
| 2‑S |
201
|
Blutgasanalyse Arteriell
|
1.2.40.0.34.5.11 |
| 2‑S |
202
|
Blutgasanalyse Venös
|
1.2.40.0.34.5.11 |
| 2‑L |
203
|
Blutgasanalyse Nabelschnurblut
|
1.2.40.0.34.5.11 |
| 1‑S |
300
|
Hämatologie
|
1.2.40.0.34.5.11 |
| 2‑S |
301
|
Blutbild
|
1.2.40.0.34.5.11 |
| 3‑L |
AKLAM
|
Akt.Lymphoz.abs.mi.
|
1.2.40.0.34.5.11 |
| 3‑L |
AKLRM
|
Akt.Lymphoz.rel.mi.
|
1.2.40.0.34.5.11 |
| 2‑S |
302
|
Knochenmark Morphologie
|
1.2.40.0.34.5.11 |
| 2‑S |
303
|
Immunphänotypisierung
|
1.2.40.0.34.5.11 |
| 3‑L |
FZA10AK
|
FZA10AK
|
1.2.40.0.34.5.11 |
| 3‑L |
FZA4R
|
FZA4R
|
1.2.40.0.34.5.11 |
| 3‑L |
FZA510AK
|
FZA510AK
|
1.2.40.0.34.5.11 |
| 3‑L |
FZA5AK
|
FZA5AK
|
1.2.40.0.34.5.11 |
| 3‑L |
FZAKLEU
|
FZAKLEU
|
1.2.40.0.34.5.11 |
| 3‑L |
FZALZP
|
FZALZP
|
1.2.40.0.34.5.11 |
| 3‑L |
FZBAL
|
FZBAL
|
1.2.40.0.34.5.11 |
| 3‑L |
FZDNA
|
FZDNA
|
1.2.40.0.34.5.11 |
| 3‑L |
FZIMSTA
|
FZIMSTA
|
1.2.40.0.34.5.11 |
| 3‑L |
FZLK
|
FZLK
|
1.2.40.0.34.5.11 |
| 3‑L |
FZLYPA
|
FZLYPA
|
1.2.40.0.34.5.11 |
| 3‑L |
FZMYVD
|
FZMYVD
|
1.2.40.0.34.5.11 |
| 3‑L |
FZMYVL
|
FZMYVL
|
1.2.40.0.34.5.11 |
| 3‑L |
FZZAP70
|
FZZAP70
|
1.2.40.0.34.5.11 |
| 2‑S |
304
|
Molekulare Diagnostik
|
1.2.40.0.34.5.11 |
| 1‑S |
400
|
Hämostaseologie
|
1.2.40.0.34.5.11 |
| 2‑S |
401
|
Hämostaseologie Globaltests
|
1.2.40.0.34.5.11 |
| 3‑L |
CFTIN
|
Clot Form.Time INTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CFTEX
|
Clot Form.Time EXTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CFTNA
|
Clot Form.Time NATEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CTAPT
|
Clotting Time APTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CTEXT
|
Clotting Time EXTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CTHEP
|
Clotting Time HEPTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CTINT
|
Clotting Time INTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
CTNAT
|
Clotting Time NATEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MCFEX
|
Max.Clot Firmn.EXTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MCFFI
|
Max.Clot Firmn.FIBT.
|
1.2.40.0.34.5.11 |
| 3‑L |
MCFIN
|
Max.Clot Firmn.INTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MCFNA
|
Max.Clot Firmn.NATEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MLEXT
|
Maximal Lyse EXTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MLINT
|
Maximal Lyse INTEM
|
1.2.40.0.34.5.11 |
| 3‑L |
MLNAT
|
Maximal Lyse NATEM
|
1.2.40.0.34.5.11 |
| 3‑L |
NRMTC
|
Normotest /KB
|
1.2.40.0.34.5.11 |
| 3‑L |
THRTC
|
Thrombotest /KB
|
1.2.40.0.34.5.11 |
| 3‑L |
NORMT
|
Normotest
|
1.2.40.0.34.5.11 |
| 3‑L |
THROT
|
Thrombotest
|
1.2.40.0.34.5.11 |
| 3‑L |
INRTT
|
INRTT
|
1.2.40.0.34.5.11 |
| 3‑L |
INRST
|
INRST
|
1.2.40.0.34.5.11 |
| 3‑L |
APTTF
|
aPTT Fakt.-sens.
|
1.2.40.0.34.5.11 |
| 3‑L |
PFAINT
|
PFAINT
|
1.2.40.0.34.5.11 |
| 2‑S |
402
|
Einzelfaktoranalysen
|
1.2.40.0.34.5.11 |
| 3‑L |
HMWKA
|
HMWK Aktivität
|
1.2.40.0.34.5.11 |
| 3‑L |
PKA
|
Präkallikrein Akt.
|
1.2.40.0.34.5.11 |
| 3‑L |
VWGPI
|
vWF Aktiv. (GPIb-R)
|
1.2.40.0.34.5.11 |
| 3‑L |
ADAA
|
ADAMTS 13 Aktivität
|
1.2.40.0.34.5.11 |
| 2‑S |
403
|
Thrombophilie Tests
|
1.2.40.0.34.5.11 |
| 3‑L |
PTTL2
|
aPTT Lupus-s. 1+2 NP
|
1.2.40.0.34.5.11 |
| 3‑L |
LABPQ
|
LA-Bestät. aPTT ql.
|
1.2.40.0.34.5.11 |
| 3‑L |
dRVV2
|
dRVVT 1+2 NP
|
1.2.40.0.34.5.11 |
| 3‑L |
LBDR1
|
LA Bst.dRVVT-R.1+1NP
|
1.2.40.0.34.5.11 |
| 3‑L |
LBDR2
|
LA Bst.dRVVT-R.1+2NP
|
1.2.40.0.34.5.11 |
| 3‑L |
LABD2
|
LA Best.dRVVT 1+2 NP
|
1.2.40.0.34.5.11 |
| 3‑L |
LABDQ
|
LA-Bestät. dRVVT ql.
|
1.2.40.0.34.5.11 |
| 3‑L |
LABDR
|
LA-Bestät. dRVVT-Rto
|
1.2.40.0.34.5.11 |
| 3‑L |
PSREG
|
Phosphatids.-AK IgG
|
1.2.40.0.34.5.11 |
| 3‑L |
PSREM
|
Phosphatids.-AK IgM
|
1.2.40.0.34.5.11 |
| 3‑L |
PCPWY
|
Protein C Pathw.
|
1.2.40.0.34.5.11 |
| 3‑L |
PCP5D
|
Prot.C Pwy(V-d.Pl.)
|
1.2.40.0.34.5.11 |
| 3‑L |
APCRZ
|
APC-Res. (Ger.Z.)
|
1.2.40.0.34.5.11 |
| 3‑L |
APCRQ
|
APC-Resistenz(qual.)
|
1.2.40.0.34.5.11 |
| 3‑L |
PA675
|
PAI-1 Mut. 675 4G/5G
|
1.2.40.0.34.5.11 |
| 3‑L |
PA844
|
PAI-1 Mut. 844A>G
|
1.2.40.0.34.5.11 |
| 1‑S |
500
|
Klinische Chemie
|
1.2.40.0.34.5.11 |
| 2‑S |
501
|
Entzündungsmarker
|
1.2.40.0.34.5.11 |
| 2‑S |
502
|
Niere/Elektrolyte
|
1.2.40.0.34.5.11 |
| 3‑L |
SAMP
|
SAMP
|
1.2.40.0.34.5.11 |
| 3‑L |
VL24U
|
VL24U
|
1.2.40.0.34.5.11 |
| 3‑L |
GFRCG
|
GFRCG
|
1.2.40.0.34.5.11 |
| 3‑L |
BUNVO
|
BUNVO
|
1.2.40.0.34.5.11 |
| 3‑L |
BUNNA
|
BUNNA
|
1.2.40.0.34.5.11 |
| 3‑L |
BUNRR
|
BUNRR
|
1.2.40.0.34.5.11 |
| 2‑S |
503
|
Kardiale Marker
|
1.2.40.0.34.5.11 |
| 2‑S |
504
|
Leber/Pankreas
|
1.2.40.0.34.5.11 |
| 2‑S |
505
|
Hämolysemarker
|
1.2.40.0.34.5.11 |
| 2‑S |
506
|
Eisenstoffwechsel
|
1.2.40.0.34.5.11 |
| 2‑S |
507
|
Glukosestoffwechsel
|
1.2.40.0.34.5.11 |
| 2‑S |
508
|
Fettstoffwechsel
|
1.2.40.0.34.5.11 |
| 2‑S |
509
|
Proteindiagnostik
|
1.2.40.0.34.5.11 |
| 3‑L |
MGRAR
|
MGRAR
|
1.2.40.0.34.5.11 |
| 3‑L |
LDLO
|
Oxidiertes LDL
|
1.2.40.0.34.5.11 |
| 1‑S |
600
|
Endokrinologie
|
1.2.40.0.34.5.11 |
| 2‑S |
601
|
Adrenocortikales System
|
1.2.40.0.34.5.11 |
| 2‑S |
602
|
Katecholamine
|
1.2.40.0.34.5.11 |
| 2‑S |
603
|
Schilddrüsendiagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
604
|
Geschlechtshormone
|
1.2.40.0.34.5.11 |
| 2‑S |
605
|
Glukosestoffwechsel
|
1.2.40.0.34.5.11 |
| 2‑S |
606
|
Endokrinologie
|
1.2.40.0.34.5.11 |
| 1‑S |
700
|
Vitamine
|
1.2.40.0.34.5.11 |
| 2‑S |
701
|
Vitamine
|
1.2.40.0.34.5.11 |
| 3‑L |
AVB12
|
AVB12
|
1.2.40.0.34.5.11 |
| 1‑S |
800
|
Tumormarker
|
1.2.40.0.34.5.11 |
| 2‑S |
801
|
Tumormarker
|
1.2.40.0.34.5.11 |
| 1‑S |
900
|
Toxikologie
|
1.2.40.0.34.5.11 |
| 2‑S |
901
|
HarnScreening
|
1.2.40.0.34.5.11 |
| 2‑S |
902
|
Blut
|
1.2.40.0.34.5.11 |
| 1‑S |
1000
|
TDM
|
1.2.40.0.34.5.11 |
| 2‑S |
1001
|
Antibiotika
|
1.2.40.0.34.5.11 |
| 2‑S |
1002
|
Virostatika
|
1.2.40.0.34.5.11 |
| 2‑S |
1003
|
Antiepileptika
|
1.2.40.0.34.5.11 |
| 2‑S |
1004
|
Kardiaka
|
1.2.40.0.34.5.11 |
| 2‑S |
1005
|
Immunsuppressiva
|
1.2.40.0.34.5.11 |
| 2‑S |
1006
|
Sonstige
|
1.2.40.0.34.5.11 |
| 1‑S |
1100
|
Virologie
|
1.2.40.0.34.5.11 |
| 2‑S |
1101
|
HIV
|
1.2.40.0.34.5.11 |
| 2‑S |
1102
|
Hepatitis A
|
1.2.40.0.34.5.11 |
| 2‑S |
1103
|
Hepatitis B
|
1.2.40.0.34.5.11 |
| 2‑S |
1104
|
Hepatitis C
|
1.2.40.0.34.5.11 |
| 2‑S |
1105
|
Komplementbindungsreaktion
|
1.2.40.0.34.5.11 |
| 2‑S |
1106
|
Immunoassays
|
1.2.40.0.34.5.11 |
| 2‑S |
1107
|
PCR-Diagnostik
|
1.2.40.0.34.5.11 |
| 3‑L |
EVPQX
|
Ent.v.-RNA qn/SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
IAPQX
|
Inf.A-V-RNAqn/SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
IBPQX
|
Inf.B-V-RNAqn/SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
MPPQX
|
MPV-RNA qn. /SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
P1PQX
|
PIV-1-RNA qn/SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
P2PQX
|
PIV-2-RNA qn/SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
P3PQX
|
PIV-3-RNA qn./SM PCR
|
1.2.40.0.34.5.11 |
| 2‑S |
1108
|
Schnelltests
|
1.2.40.0.34.5.11 |
| 1‑S |
1200
|
Bakteriologie
|
1.2.40.0.34.5.11 |
| 2‑S |
1201
|
Syphilis-Diagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1202
|
STD
|
1.2.40.0.34.5.11 |
| 2‑S |
1203
|
Borrelienserologie
|
1.2.40.0.34.5.11 |
| 2‑S |
1204
|
Chl. Psitakii Diagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1205
|
Schnelltests
|
1.2.40.0.34.5.11 |
| 2‑S |
1206
|
Tuberkulose Diagnostik
|
1.2.40.0.34.5.11 |
| 3‑L |
MTQPX
|
MTB-DNA qn. /SM PCR
|
1.2.40.0.34.5.11 |
| 3‑L |
MTBP$
|
MTBP$
|
1.2.40.0.34.5.11 |
| 3‑L |
MTBP+
|
MTBP+
|
1.2.40.0.34.5.11 |
| 3‑L |
MTBPM
|
MTBPM
|
1.2.40.0.34.5.11 |
| 3‑L |
MTBPR
|
MTBPR
|
1.2.40.0.34.5.11 |
| 3‑L |
MTBPU
|
MTBPU
|
1.2.40.0.34.5.11 |
| 2‑S |
1207
|
Mykoplasmen Diagnostik
|
1.2.40.0.34.5.11 |
| 3‑L |
MYPQX
|
Myc.pn.DNA qn/SM PCR
|
1.2.40.0.34.5.11 |
| 2‑S |
1208
|
Malariasuche
|
1.2.40.0.34.5.11 |
| 3‑L |
PLLDH
|
Plasmodien-LDH /B
|
1.2.40.0.34.5.11 |
| 1‑S |
1300
|
Autoantikörperdiagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1301
|
Rheumatoide Arthritis-assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
CCPAK
|
CCP-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
MCVAK
|
MCV-AK
|
1.2.40.0.34.5.11 |
| 2‑S |
1302
|
Kollagenose-assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
CHRTF
|
ANA chromosom. Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
NUKTF
|
ANA nukleolär Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
HOMTF
|
ANA homogen Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
HOMTF
|
ANA homogen Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SPFTF
|
ANA speck.fein Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SPATF
|
ANA speck.atyp.Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
NUKTF
|
ANA nukleolär Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
NDQF
|
ANA nucl. dot ql. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
NDTF
|
ANA nucl. dot Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
MNDQF
|
ANA m.nucl.dot ql.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
MNDTF
|
ANA m.nucl.dot Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
KMTTF
|
ANA Kernmatrix Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SPIQF
|
ANA Spindel qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SPITF
|
ANA Spindel Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
CSMTF
|
ANA centrosom. Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PCAQF
|
PCNA-AK qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PCATF
|
PCNA-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PRAQF
|
Kernporen-AK ql. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PRATF
|
Kernporen-AK T. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
HP2FI
|
HEP2-Ze. IF Interpr.
|
1.2.40.0.34.5.11 |
| 3‑L |
NSMAK
|
Nukleosomen-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
S52AK
|
SS-A/Ro-52-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
S60AK
|
SS-A/Ro-60-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
CNBAK
|
CENP-B-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
S52AQ
|
SS-A/Ro-52-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
S60AQ
|
SS-A/Ro-60-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
RNPSQ
|
RNPSQ
|
1.2.40.0.34.5.11 |
| 3‑L |
U170Q
|
U1-snRNP-70-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
U170Q
|
U1-snRNP-70-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
U1RAQ
|
U1-snRNP-A-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
U1RGQ
|
U1-snRNP-AK ql.
|
1.2.40.0.34.5.11 |
| 3‑L |
U1RGQ
|
U1-snRNP-AK ql.
|
1.2.40.0.34.5.11 |
| 3‑L |
U1RCQ
|
U1-snRNP-C-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
SMBAQ
|
SmB-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
SMDAQ
|
SmD-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
CNBAQ
|
CENP-B-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
GOAQF
|
Golgi-AK qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
GOATF
|
Golgi-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
LYATF
|
Lysosomen-AK Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
RIBQF
|
Ribosomale-AK ql. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
RPAQF
|
RNA-Polym.-AK ql. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
RPATF
|
RNA-Polym.-AK Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PMSQF
|
PM-Scl-AK qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PMSTF
|
PM-Scl-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
VMATF
|
Vimentin-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
VNATF
|
Vinkulin-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
P7AQF
|
PL-7/PL-12-AK ql. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
P7ATF
|
PL-7/PL-12-AK Ti. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SRATF
|
SRP-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SRPAK
|
SRP-AK
|
1.2.40.0.34.5.11 |
| 2‑S |
1303
|
Lebererkrankungen-assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
LKAQF
|
LKM-AK qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SMAFI
|
SMA(ASMA)IF Interpr.
|
1.2.40.0.34.5.11 |
| 3‑L |
SMAI
|
SMA(ASMA) Interpret.
|
1.2.40.0.34.5.11 |
| 3‑L |
AKAQF
|
Aktin-AK qual. IF
|
1.2.40.0.34.5.11 |
| 3‑L |
AKATF
|
Aktin-AK Titer IF
|
1.2.40.0.34.5.11 |
| 3‑L |
AMM4
|
AMA-M4
|
1.2.40.0.34.5.11 |
| 3‑L |
AMM9
|
AMA-M9
|
1.2.40.0.34.5.11 |
| 3‑L |
SLAAQ
|
SLA/LP-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
FAKTA
|
F-Aktin-AK
|
1.2.40.0.34.5.11 |
| 3‑L |
FAKAQ
|
F-Aktin-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
GP2AQ
|
GP210-AK qual.
|
1.2.40.0.34.5.11 |
| 2‑S |
1304
|
Perniziöse Anämie assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 2‑S |
1305
|
Vasculitis-assoziierte Antikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
XANQF
|
x-ANCA(atyp.p) ql.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
AANTF
|
Atyp. ANCA Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
PR3AC
|
PR3-AK cELISA
|
1.2.40.0.34.5.11 |
| 3‑L |
MPOC
|
MPO-AK cELISA
|
1.2.40.0.34.5.11 |
| 3‑L |
ELAAQ
|
Elastase-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
CATAQ
|
Cathepsin-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
LYSAQ
|
Lysozym-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
LACAQ
|
Lactoferrin-AK qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
BPIAQ
|
BPI-AK qual.
|
1.2.40.0.34.5.11 |
| 2‑S |
1306
|
Goodpasture Syndrom assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 2‑S |
1307
|
IBD assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
ASCAQ
|
ASCA qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
TTAGQ
|
tTGA IgG qual.
|
1.2.40.0.34.5.11 |
| 3‑L |
TTGAQ
|
tTGA qual.
|
1.2.40.0.34.5.11 |
| 2‑S |
1308
|
Diabetes Mellitus assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 2‑S |
1309
|
Paraneoplasie assoziierte Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
KIAQ
|
Ki-AK qual.
|
1.2.40.0.34.5.11 |
| 2‑S |
1310
|
Sonstige Autoantikörper
|
1.2.40.0.34.5.11 |
| 3‑L |
SPDTF
|
Speicheldr.-AK Ti.IF
|
1.2.40.0.34.5.11 |
| 3‑L |
SRAQF
|
SRP-AK qual. IF
|
1.2.40.0.34.5.11 |
| 1‑S |
1400
|
Harndiagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1401
|
Harnstreifen
|
1.2.40.0.34.5.11 |
| 3‑L |
ERYSU
|
ERYSU
|
1.2.40.0.34.5.11 |
| 2‑S |
1402
|
Harnsediment
|
1.2.40.0.34.5.11 |
| 3‑L |
G1ERV
|
G1-Erythrozyt.rl./US
|
1.2.40.0.34.5.11 |
| 3‑L |
GLERV
|
Glomerul.Ery.rel./US
|
1.2.40.0.34.5.11 |
| 3‑L |
PILZV
|
Pilze /US
|
1.2.40.0.34.5.11 |
| 3‑L |
RUEPV
|
Rundepithelien /US
|
1.2.40.0.34.5.11 |
| 3‑L |
PSZLV
|
Pseudozylinder /US
|
1.2.40.0.34.5.11 |
| 3‑L |
ZGLMU
|
Ziegelmehlsedim. /U
|
1.2.40.0.34.5.11 |
| 2‑S |
1403
|
Harnchemie
|
1.2.40.0.34.5.11 |
| 3‑L |
MGU
|
MGU
|
1.2.40.0.34.5.11 |
| 3‑L |
B1GRU
|
B1GRU
|
1.2.40.0.34.5.11 |
| 3‑L |
B2GRU
|
B2GRU
|
1.2.40.0.34.5.11 |
| 3‑L |
B1GLU
|
B1GLU
|
1.2.40.0.34.5.11 |
| 3‑L |
B2GLU
|
B2GLU
|
1.2.40.0.34.5.11 |
| 3‑L |
FLAMU
|
FLAMU
|
1.2.40.0.34.5.11 |
| 2‑S |
1404
|
Katecholamine
|
1.2.40.0.34.5.11 |
| 2‑S |
1405
|
Kortikoide
|
1.2.40.0.34.5.11 |
| 1‑S |
1500
|
Stuhldiagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1501
|
Stuhldiagnostik
|
1.2.40.0.34.5.11 |
| 1‑S |
1600
|
Liquordiagnostik
|
1.2.40.0.34.5.11 |
| 2‑S |
1601
|
Liquordiagnostik
|
1.2.40.0.34.5.11 |
| 3‑L |
MNZRL
|
MNZRL
|
1.2.40.0.34.5.11 |
| 3‑L |
NEURL
|
NEURL
|
1.2.40.0.34.5.11 |
| 3‑L |
FKAPL
|
FKAPL
|
1.2.40.0.34.5.11 |
| 3‑L |
FLAML
|
FLAML
|
1.2.40.0.34.5.11 |
| 3‑L |
FKAPI
|
FKAPI
|
1.2.40.0.34.5.11 |
| 1‑S |
1700
|
Sondermaterialien
|
1.2.40.0.34.5.11 |
| 2‑S |
1701
|
Sondermaterialien
|
1.2.40.0.34.5.11 |
| 3‑L |
THRX
|
THRX
|
1.2.40.0.34.5.11 |
| 3‑L |
ERYX
|
ERYX
|
1.2.40.0.34.5.11 |
| 3‑L |
HBX
|
HBX
|
1.2.40.0.34.5.11 |
| 3‑L |
HKTX
|
HKTX
|
1.2.40.0.34.5.11 |
| 3‑L |
NEUAX
|
NEUAX
|
1.2.40.0.34.5.11 |
| 3‑L |
EOSAX
|
EOSAX
|
1.2.40.0.34.5.11 |
| 3‑L |
BASAX
|
BASAX
|
1.2.40.0.34.5.11 |
| 3‑L |
LYMAX
|
LYMAX
|
1.2.40.0.34.5.11 |
| 3‑L |
MONAX
|
MONAX
|
1.2.40.0.34.5.11 |
| 3‑L |
IMGAX
|
IMGAX
|
1.2.40.0.34.5.11 |
| 3‑L |
EOSRX
|
EOSRX
|
1.2.40.0.34.5.11 |
| 3‑L |
BASRX
|
BASRX
|
1.2.40.0.34.5.11 |
| 3‑L |
IMGRX
|
IMGRX
|
1.2.40.0.34.5.11 |
| 3‑L |
B1GRX
|
B1GRX
|
1.2.40.0.34.5.11 |
| 3‑L |
B2GRX
|
B2GRX
|
1.2.40.0.34.5.11 |
| 3‑L |
B1GX
|
B1GX
|
1.2.40.0.34.5.11 |
| 3‑L |
B2GX
|
B2GX
|
1.2.40.0.34.5.11 |
| 3‑L |
FERRX
|
FERRX
|
1.2.40.0.34.5.11 |
| 2‑S |
1702
|
Peritonealdialysat
|
1.2.40.0.34.5.11 |
| 3‑L |
THRY
|
THRY
|
1.2.40.0.34.5.11 |
| 3‑L |
ERYY
|
ERYY
|
1.2.40.0.34.5.11 |
| 3‑L |
HBY
|
HBY
|
1.2.40.0.34.5.11 |
| 3‑L |
HKTY
|
HKTY
|
1.2.40.0.34.5.11 |
| 3‑L |
NEURY
|
NEURY
|
1.2.40.0.34.5.11 |
| 3‑L |
EOSRY
|
EOSRY
|
1.2.40.0.34.5.11 |
| 3‑L |
BASRY
|
BASRY
|
1.2.40.0.34.5.11 |
| 3‑L |
LYMRY
|
LYMRY
|
1.2.40.0.34.5.11 |
| 3‑L |
MONRY
|
MONRY
|
1.2.40.0.34.5.11 |
| 3‑L |
TPY
|
TPY
|
1.2.40.0.34.5.11 |
| 3‑L |
ALBY
|
ALBY
|
1.2.40.0.34.5.11 |
| 3‑L |
CHOLY
|
CHOLY
|
1.2.40.0.34.5.11 |
| 3‑L |
TRIGY
|
TRIGY
|
1.2.40.0.34.5.11 |
| 1‑S |
1800
|
Allergiediagnostik/Globalmarker
|
1.2.40.0.34.5.11 |
| 2‑S |
1801
|
Allergiediagnostik/Globalmarker
|
1.2.40.0.34.5.11 |
| 3‑L |
DAO
|
DAO
|
1.2.40.0.34.5.11 |
| 1‑S |
1900
|
Allergiediagnostik Spez. IGE
|
1.2.40.0.34.5.11 |
| 2‑S |
1901
|
Gräserpollen RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1902
|
Baumpollen RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1903
|
Kräuterpollen RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1904
|
Milben RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1905
|
Epidermale Tierallergene RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1906
|
Mikroorganismen RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1907
|
Nahrungsmittel RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1908
|
Insektengifte RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1909
|
Berufliche Allergene RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1910
|
Diverse Allergene RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1911
|
Medikamente RAST Klassen
|
1.2.40.0.34.5.11 |
| 2‑S |
1912
|
Gräserpollen IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1913
|
Baumpollen IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1914
|
Kräuterpollen IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1915
|
Milben IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1916
|
Epidermale Tierallergene IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1917
|
Mikroorganismen IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1918
|
Nahrungsmittel IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1919
|
Insektengifte IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1920
|
Berufliche Allergene IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1921
|
Diverse Allergene IGE quant.
|
1.2.40.0.34.5.11 |
| 2‑S |
1922
|
Medikamente IGE quant.
|
1.2.40.0.34.5.11 |
|
| |
Value Set ELGA_LaborparameterErgaenzung 2013‑09‑12
Veraltet
